Dr. Alotaiq is an expert in molecular and clinical pharmacology with extensive experience in cell-based analysis and translational research. As the principal investigator, he oversees the strategic direction of the project, ensuring alignment with clinical relevance and regulatory pathways. His background bridges pharmaceutical sciences and biological systems, providing essential insight for experimental validation and therapeutic translation.